Newsfile Corp
12 Nov 2026, 17:47 UTC · 1h ago
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX
Impact · against what's priced in
Tenax Therapeutics faces increased legal risk and potential cash outflows due to a securities class action lawsuit. The upcoming December 28 deadline for lead plaintiff applications may trigger negative sentiment and increased volatility.
- TENX−0.40
No priced-in read yet





